(Q30061950)

26 May 2017

title

Requirements for global elimination of hepatitis B: a modelling study (English)

1 reference

26 May 2017

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mark Thursz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Elisa Sicuri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Timothy B Hallett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Lesong Conteh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Stefan Wiktor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Daniel Low-Beer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

13 September 2016

1 reference

Lancet Infectious Diseases

26 May 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

1399-1408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Effects of Maternal Screening and Universal Immunization to Prevent Mother-to-Infant Transmission of HBV

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Individualized management of pregnant women with high hepatitis B virus DNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

1 reference

7 January 2021

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Hepatitis B immunization strategies: timing is everything

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

The e antigen and vertical transmission of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Household catastrophic health expenditure: a multicountry analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Defeating AIDS--advancing global health

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

Model based analysis of hepatitis B vaccination strategies in the Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

The evolution of the population-based cancer registry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930204-3

7 January 2021

10.1016/S1473-3099(16)30204-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27638356%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference